Dr. Taub quoted in Dermatology Times "Navigating neurotoxins’ differences"

November 26, 2013

The Dermatology Times
By Heather Onorati
November 26, 2013

"We now have three neurotoxins in our marketplace. Do you feel that these neurotoxins differ, and if so, how?

Amy Taub, M.D., dermatologist, Chicago: I use all three. I definitely think they're different. I don't know that I can explain why. I primarily use Botox (onabotulinumtoxinA, Allergan), but I think it's somewhat out of habit. I've done it for so long that I feel like it’s my violin that I just know how to play really well.

I do use Dysport (abobotulinumtoxinA, Medicis) around the eyes because it does give you a little bit more spread and a little more freeze. And there I think it’s OK unless somebody has really large orbicularis or ocular muscle inferiorly, because if it’s really frozen then sometimes that’ll become more prominent. But I don’t like it in the forehead.

If the Botox stops working as long for a patient, I'll use Dysport. I’ve had some people who’ve done well with Dysport and I’ve had some people who didn’t do well with Botox or Dysport, and so we used Xeomin (incobotulinumtoxinA, Merz) and we were successful with that. So there’s probably some immunological reaction to the proteins, is my thought.” Read More.